Bloomberg UK: Dayton Therapeutics Discovers New…

Dayton Therapeutics has announced that the company is using its AI-powered genetic and molecular research model for investigating new therapeutic uses of clinical stage drug candidates where development has been discontinued – in particular satraplatin. Satraplatin is…

Categories: